ConductScience.org, home

Trial · NCT03366103

Outcomes12

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYNumber of Participants With Dose Limiting Toxicities (Phase I)Up to 30 days after last treatment, an average of 3 monthsPhase 1 participants were included in this analysis. Please see AE section for additional details.ParticipantsCOUNT_OF_PARTICIPANTS
PRIMARYOverall Response Rate (ORR) (Phase II)Up to 1.5 yearsOnly one participant was enrolled.ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYOccurrence of a Bi-directional Pharmacokinetic (PK) InteractionThrough Day 15Participants in both phases were included. Some data was not collected at each timepoint.ng/mlMEAN
SECONDARYNumber of Participants Experiencing Adverse Events by Grade (Phase II)Up to 1.5 yearsOnly one participant was enrolled.participantsNUMBER
SECONDARYProgression Free Survival (PFS) (Phase II)Up to 1.5 yearsOnly one participant was enrolled.ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYOverall Survival (OS) at Year 1 (Phase II)At Year 1Only one participant was enrolled.ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYDisease Control Rate (Phase II)Up to 1.5 yearsOnly one participant was enrolled.ParticipantsCOUNT_OF_PARTICIPANTS
OTHER_PRE_SPECIFIEDChange in p4EBP1 ExpressionBaseline up to 1.5 yearsData was not collected.
OTHER_PRE_SPECIFIEDChange in Ratio p4EBP1/4EBP1Baseline up to 1.5 yearsData was not collected.
OTHER_PRE_SPECIFIEDChange in Ratio pS6/S6Baseline up to 1.5 yearsData was not collected.
OTHER_PRE_SPECIFIEDChange in BAX and MCl-1 ExpressionBaseline up to 1.5 yearsData was not collected.
OTHER_PRE_SPECIFIEDPharmacodynamic ParametersUp to 1.5 yearsData was not collected.

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03366103/outcomes